# Edesa Biotech (EDSA) — Earnings

EDSA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/edsa/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.37 |
| EPS estimate | −$0.27 |
| EPS surprise | −36.86% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Dec 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1540159/000117184325007913/f8k_121125.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2025 | Dec 12, 2025 | −$0.27 | −$0.37 | -36.86% | — | — |
| Q3 2025 | Aug 8, 2025 | −$0.26 | −$0.25 | 5.05% | — | — |
| Q2 2025 | May 14, 2025 | −$0.42 | −$0.30 | 28.57% | — | — |
| Q1 2025 | Feb 14, 2025 | −$0.31 | −$0.48 | -54.84% | — | — |
| Q4 2024 | Dec 13, 2024 | −$0.54 | −$0.29 | 46.30% | — | — |
| Q3 2024 | Aug 9, 2024 | −$0.58 | −$0.52 | 10.34% | — | — |
| Q2 2024 | May 10, 2024 | −$0.69 | −$0.58 | 16.34% | — | — |
| Q1 2024 | Feb 9, 2024 | −$1.21 | −$0.54 | 55.37% | — | — |
| Q4 2023 | Dec 15, 2023 | −$0.70 | −$0.57 | 18.95% | — | — |
| Q3 2023 | Aug 9, 2023 | −$1.10 | −$0.70 | 36.17% | — | — |
| Q2 2023 | May 11, 2023 | −$1.14 | −$0.84 | 26.53% | — | — |
| Q1 2023 | Feb 10, 2023 | −$1.24 | −$0.91 | 26.42% | — | — |
| Q4 2022 | Dec 16, 2022 | −$2.19 | −$1.05 | 52.13% | — | — |
| Q3 2022 | Aug 12, 2022 | −$2.59 | −$2.59 | 0.00% | — | — |
| Q2 2022 | May 13, 2022 | −$2.57 | −$2.31 | 10.00% | — | — |
| Q1 2022 | Feb 14, 2022 | −$2.80 | −$2.31 | 17.50% | — | — |
| Q4 2021 | Dec 28, 2021 | −$2.57 | −$2.03 | 20.91% | — | — |
| Q3 2021 | Aug 13, 2021 | −$2.24 | −$2.52 | -12.50% | — | — |
| Q2 2021 | May 14, 2021 | −$2.07 | −$1.33 | 35.59% | — | — |
| Q1 2021 | Feb 16, 2021 | −$1.47 | −$1.82 | -23.81% | $50,000.00 | — |

## Frequently Asked Questions

### When did Edesa Biotech (EDSA) last report earnings?

Edesa Biotech last reported on Dec 12, 2025, covering fiscal Q4 2025.

### Did EDSA beat earnings estimates?

No. Edesa Biotech reported EPS of −$0.37 for Q4 2025 against a −$0.27 estimate — a 36.86% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).